Ballentine Partners, LLC Viatris Inc Transaction History
Ballentine Partners, LLC
- $5.74 Billion
- Q1 2025
A detailed history of Ballentine Partners, LLC transactions in Viatris Inc stock. As of the latest transaction made, Ballentine Partners, LLC holds 16,703 shares of VTRS stock, worth $152,665. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,703
Previous 20,582
18.85%
Holding current value
$152,665
Previous $256,000
43.36%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding VTRS
# of Institutions
1,127Shares Held
959MCall Options Held
4.15MPut Options Held
2.65M-
Vanguard Group Inc Valley Forge, PA145MShares$1.32 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$847 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD74.5MShares$681 Million0.08% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az64.9MShares$594 Million3.35% of portfolio
-
State Street Corp Boston, MA61.5MShares$562 Million0.02% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $11.1B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...